CN Patent
CN107759503A — 一种四环素衍生物及其用途
Assigned to Sichuan Kelun Botai Biological Pharmaceutical Ltd By Share Ltd · Expires 2018-03-06 · 8y expired
What this patent protects
本发明涉及一种四环素衍生物,其制备方法及其用途。具体地,本发明涉及一种通式(Ⅰ)的化合物,或其异构体、盐、酯、溶剂化物或水合物、化学保护的形式和前药代谢产物、晶型。并且,本发明还涉及该化合物的制备方法及用途。
USPTO Abstract
本发明涉及一种四环素衍生物,其制备方法及其用途。具体地,本发明涉及一种通式(Ⅰ)的化合物,或其异构体、盐、酯、溶剂化物或水合物、化学保护的形式和前药代谢产物、晶型。并且,本发明还涉及该化合物的制备方法及用途。
Drugs covered by this patent
- Xerava (ERAVACYCLINE DIHYDROCHLORIDE) · Tetraphase Pharms
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.